On 7 November 2024, we held a conference call to present our results for the nine first months of 2024.
London conference call webcast
On 6 November 2024, we announced our financial results for the nine first months of 2024.
Download financial workbook (xlsx)
Investor presentation (ipaper)
Go to the conference call webcast
On 8 August 2024, we held a conference call to present our results for the six first months of 2024.
On 7 August 2024, we announced our financial results for the six first months of 2024.
Investor presentation (iPaper)
We announced our financial results for the three first months of 2024.
Novo Nordisk A/S announced financial results for the full year of 2023:
Novo Nordisk A/S hosted a R&D investor call in relation to the
annual American Heart Association (AHA) conference. This year the
conference is hosted in Philadelphia, US.
Presentation
(Webcast)
Presentation (pdf)
Novo Nordisk A/S hosted a R&D investor call in relation to the annual ADA conference. This year the conference is hosted in San Diego, CA.
Full-year 2022 financial results were published 01 February 2023, 7:30 CET:
In connection with ADA 82nd Scientific Sessions Novo Nordisk A/S will host an investor event.